1. Chalya PL, Mabula JB, Koy M, McHembe MD, Jaka HM, Kabangila R, et al. Clinical profile and outcome of surgical treatment of perforated peptic ulcers in Northwestern Tanzania: A tertiary hospital experience. World J Emerg Surg. 2011. 6:31.
Article
2. Mäkelä J, Laitinen S, Kairaluoma MI. Complications of peptic ulcer disease before and after the introduction of H2-receptor antagonists. Hepatogastroenterology. 1992. 39:144–148.
3. Noguiera C, Silva AS, Santos JN, Silva AG, Ferreira J, Matos E, et al. Perforated peptic ulcer: main factors of morbidity and mortality. World J Surg. 2003. 27:782–787.
Article
4. Scheeres DE, DeKryger LL, Dean RE. Surgical treatment of peptic ulcer disease before and after introduction of H2 blockers. Am Surg. 1987. 53:392–395.
5. Imhof M, Epstein S, Ohmann C, Röher HD. Duration of survival after peptic ulcer perforation. World J Surg. 2008. 32:408–412.
Article
6. Rahman MM, Islam MS, Flora S, Akhter SF, Hossain S, Karim F. Mortality in perforated peptic ulcer patients after selective management of stratified poor risk cases. World J Surg. 2007. 31:2341–2344.
Article
7. Bittner R, Butters M, Ulrich M, Uppenbrink S, Beger HG. Total gastrectomy. Updated operative mortality and long-term survival with particular reference to patients older than 70 years of age. Ann Surg. 1996. 224:37–42.
8. Habu H, Endo M. Gastric cancer in elderly patients--results of surgical treatment. Hepatogastroenterology. 1989. 36:71–74.
9. Jeong SH, Ahn HS, Yoo MW, Cho JJ, Lee HJ, Kim HH, et al. Increased morbidity rates in patients with heart disease or chronic liver disease following radical gastric surgery. J Surg Oncol. 2010. 101:200–204.
Article
10. Fitz-Henry J. The ASA classification and peri-operative risk. Ann R Coll Surg Engl. 2011. 93:185–187.
Article
11. Lohsiriwat V, Prapasrivorakul S, Lohsiriwat D. Perforated peptic ulcer: clinical presentation, surgical outcomes, and the accuracy of the Boey scoring system in predicting postoperative morbidity and mortality. World J Surg. 2009. 33:80–85.
Article
12. Boey J, Choi SK, Poon A, Alagaratnam TT. Risk stratification in perforated duodenal ulcers. A prospective validation of predictive factors. Ann Surg. 1987. 205:22–26.
13. Linder MM, Wacha H, Feldmann U, Wesch G, Streifensand RA, Gundlach E. The Mannheim peritonitis index. An instrument for the intraoperative prognosis of peritonitis. Chirurg. 1987. 58:84–92.
14. Lau WY, Leung KL, Zhu XL, Lam YH, Chung SC, Li AK. Laparoscopic repair of perforated peptic ulcer. Br J Surg. 1995. 82:814–816.
Article
15. Sanabria AE, Morales CH, Villegas MI. Laparoscopic repair for perforated peptic ulcer disease. Cochrane Database Syst Rev. 2005. (4):CD004778.
Article
16. Siu WT, Leong HT, Law BK, Chau CH, Li AC, Fung KH, et al. Laparoscopic repair for perforated peptic ulcer: a randomized controlled trial. Ann Surg. 2002. 235:313–319.
17. Hwang J, Kim JM, Kim HS. Clinical study and factors influencing postoperative morbidity in perforated peptic ulcer patients. J Korean Surg Soc. 2007. 73:130–137.
18. Heo IU, Kim HK, Lee SZ. A clinical study on peptic ulcer perforation. J Korean Surg Soc. 1984. 27:567–575.
19. Kang G, Kim CY, Min YD, Kim SH. Results of surgical treatment for perforated peptic ulcer. J Korean Surg Soc. 1993. 44:214–222.
20. Park JS, Kang JK. A clinical review in ulcer perforation of stomach and duodenum. J Korean Surg Soc. 1983. 25:736–744.
21. Kang RG, Jung SY, Suh JW. A clinical evaluation and follow up results of the surgical management on 172 patients with perforated peptic ulcer. J Korean Surg Soc. 1992. 42:292–303.
22. Lee HW, Ahn SI, Yang DH, Lee CH, Sohn JH, Kwon OJ, et al. A clinical review of peptic ulcer during 22 yrs (1968~1989). J Korean Surg Soc. 1993. 44:159–174.
23. Bae SW, Hwang JY, Lee YG. A clinical study of perforated peptic ulcer. J Korean Surg Soc. 1989. 36:737–743.
24. Shin HW, Moon SH, Lee YC, Kim JS, Chung BW, Chung KS. APACHE II score in emergency operation for perforation of gastroduodenal ulcer. J Korean Surg Soc. 1994. 47:501–509.
25. Sonnenberg A. Changes in physician visits for gastric and duodenal ulcer in the United States during 1958-1984 as shown by National Disease and Therapeutic Index (NDTI). Dig Dis Sci. 1987. 32:1–7.
Article
26. Testini M, Portincasa P, Piccinni G, Lissidini G, Pellegrini F, Greco L. Significant factors associated with fatal outcome in emergency open surgery for perforated peptic ulcer. World J Gastroenterol. 2003. 9:2338–2340.
Article
27. Ko JW, Hong SJ, Ban JY, Kim JH. Risk factors associated with mortality in emergency surgery for perforated peptic ulcer. J Korean Surg Soc. 2004. 67:373–378.
28. Hirsch IB, McGill JB. Role of insulin in management of surgical patients with diabetes mellitus. Diabetes Care. 1990. 13:980–991.
Article
29. Stagnaro-Green A. Perioperative glucose control: does it really matter? Mt Sinai J Med. 1991. 58:299–304.
30. Schiff RL, Welsh GA. Perioperative evaluation and management of the patient with endocrine dysfunction. Med Clin North Am. 2003. 87:175–192.
Article